B. Sarin, B. Bindhu, P. Raghu Kumar, S. Sumeesh, B. Saju
{"title":"立体定向全身放射治疗(SBRT)肺部治疗的Acuros®XB和AAA算法的剂量学准确性:用PRIMO蒙特卡罗代码进行评估","authors":"B. Sarin, B. Bindhu, P. Raghu Kumar, S. Sumeesh, B. Saju","doi":"10.1017/S1460396922000346","DOIUrl":null,"url":null,"abstract":"Abstract Purpose: The study aimed to compare the dosimetric performance of Acuros® XB (AXB) and anisotropic analytical algorithm (AAA) for lung SBRT plans using Monte Carlo (MC) simulations. Methods: We compared the dose calculation algorithms AAA and either of the dose reporting modes of AXB (dose to medium (AXB-Dm) or dose to water (AXB-Dw)) algorithms implemented in Eclipse® (Varian Medical Systems, Palo Alto, CA) Treatment planning system (TPS) with MC. PRIMO code was used for the MC simulations. The TPS-calculated dose profiles obtained with a multi-slab heterogeneity phantom were compared to MC. A lung phantom with a tumour was used to validate TPS algorithms using different beam delivery techniques. 2D gamma values obtained from Gafchromic film measurements in the tumour isocentre plane were compared with TPS algorithms and MC. Ten VMAT SBRT plans generated in TPS with each algorithm were recalculated with a PRIMO MC system for identical beam parameters for the clinical plan validation. A dose–volume histogram (DVH) based plan comparison and a 3D global gamma analysis were performed. Results: AXB demonstrated better agreement with MC and film measurements in the lung phantom validation, with good agreement in PDD, profiles and gamma analysis. AAA showed an overestimated PDD, a significant difference in dose profiles and a lower gamma pass rate near the field borders. With AAA, there was a dose overestimation at the periphery of the tumour. For clinical plan validation, AXB demonstrated higher agreement with MC than AAA. Conclusions: AXB provided better agreement with MC than AAA in the phantom and clinical plan evaluations.","PeriodicalId":44597,"journal":{"name":"Journal of Radiotherapy in Practice","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2022-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dosimetric accuracy of Acuros® XB and AAA algorithms for stereotactic body radiotherapy (SBRT) lung treatments: evaluation with PRIMO Monte Carlo code\",\"authors\":\"B. Sarin, B. Bindhu, P. Raghu Kumar, S. Sumeesh, B. Saju\",\"doi\":\"10.1017/S1460396922000346\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract Purpose: The study aimed to compare the dosimetric performance of Acuros® XB (AXB) and anisotropic analytical algorithm (AAA) for lung SBRT plans using Monte Carlo (MC) simulations. Methods: We compared the dose calculation algorithms AAA and either of the dose reporting modes of AXB (dose to medium (AXB-Dm) or dose to water (AXB-Dw)) algorithms implemented in Eclipse® (Varian Medical Systems, Palo Alto, CA) Treatment planning system (TPS) with MC. PRIMO code was used for the MC simulations. The TPS-calculated dose profiles obtained with a multi-slab heterogeneity phantom were compared to MC. A lung phantom with a tumour was used to validate TPS algorithms using different beam delivery techniques. 2D gamma values obtained from Gafchromic film measurements in the tumour isocentre plane were compared with TPS algorithms and MC. Ten VMAT SBRT plans generated in TPS with each algorithm were recalculated with a PRIMO MC system for identical beam parameters for the clinical plan validation. A dose–volume histogram (DVH) based plan comparison and a 3D global gamma analysis were performed. Results: AXB demonstrated better agreement with MC and film measurements in the lung phantom validation, with good agreement in PDD, profiles and gamma analysis. AAA showed an overestimated PDD, a significant difference in dose profiles and a lower gamma pass rate near the field borders. With AAA, there was a dose overestimation at the periphery of the tumour. For clinical plan validation, AXB demonstrated higher agreement with MC than AAA. Conclusions: AXB provided better agreement with MC than AAA in the phantom and clinical plan evaluations.\",\"PeriodicalId\":44597,\"journal\":{\"name\":\"Journal of Radiotherapy in Practice\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2022-12-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Radiotherapy in Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/S1460396922000346\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Radiotherapy in Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/S1460396922000346","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
摘要
摘要目的:本研究旨在使用蒙特卡罗(MC)模拟比较Acuros®XB(AXB)和各向异性分析算法(AAA)在肺SBRT计划中的剂量测定性能。方法:我们将Eclipse®(Varian Medical Systems,Palo Alto,CA)治疗计划系统(TPS)中实施的剂量计算算法AAA和AXB的剂量报告模式(剂量-介质(AXB-Dm)或剂量-水(AXB-Dw))算法与MC进行了比较。PRIMO代码用于MC模拟。将用多板异质性体模获得的TPS计算的剂量分布与MC进行比较。使用带有肿瘤的肺体模使用不同的束传递技术验证TPS算法。将从肿瘤等中心平面的Gafchromic膜测量中获得的2D伽马值与TPS算法和MC进行比较。使用PRIMO MC系统重新计算TPS中生成的10个VMAT SBRT计划,以获得相同的波束参数,用于临床计划验证。进行了基于剂量-体积直方图(DVH)的计划比较和3D全局伽马分析。结果:在肺体模验证中,AXB与MC和胶片测量显示出更好的一致性,在PDD、剖面图和伽玛分析中表现出良好的一致性。AAA显示PDD被高估,剂量分布存在显著差异,并且场边界附近的伽马通过率较低。对于AAA,肿瘤周围的剂量估计过高。在临床计划验证方面,AXB与MC的一致性高于AAA。结论:在体模和临床计划评估中,AXB与MC的一致性优于AAA。
Dosimetric accuracy of Acuros® XB and AAA algorithms for stereotactic body radiotherapy (SBRT) lung treatments: evaluation with PRIMO Monte Carlo code
Abstract Purpose: The study aimed to compare the dosimetric performance of Acuros® XB (AXB) and anisotropic analytical algorithm (AAA) for lung SBRT plans using Monte Carlo (MC) simulations. Methods: We compared the dose calculation algorithms AAA and either of the dose reporting modes of AXB (dose to medium (AXB-Dm) or dose to water (AXB-Dw)) algorithms implemented in Eclipse® (Varian Medical Systems, Palo Alto, CA) Treatment planning system (TPS) with MC. PRIMO code was used for the MC simulations. The TPS-calculated dose profiles obtained with a multi-slab heterogeneity phantom were compared to MC. A lung phantom with a tumour was used to validate TPS algorithms using different beam delivery techniques. 2D gamma values obtained from Gafchromic film measurements in the tumour isocentre plane were compared with TPS algorithms and MC. Ten VMAT SBRT plans generated in TPS with each algorithm were recalculated with a PRIMO MC system for identical beam parameters for the clinical plan validation. A dose–volume histogram (DVH) based plan comparison and a 3D global gamma analysis were performed. Results: AXB demonstrated better agreement with MC and film measurements in the lung phantom validation, with good agreement in PDD, profiles and gamma analysis. AAA showed an overestimated PDD, a significant difference in dose profiles and a lower gamma pass rate near the field borders. With AAA, there was a dose overestimation at the periphery of the tumour. For clinical plan validation, AXB demonstrated higher agreement with MC than AAA. Conclusions: AXB provided better agreement with MC than AAA in the phantom and clinical plan evaluations.
期刊介绍:
Journal of Radiotherapy in Practice is a peer-reviewed journal covering all of the current modalities specific to clinical oncology and radiotherapy. The journal aims to publish research from a wide range of styles and encourage debate and the exchange of information and opinion from within the field of radiotherapy practice and clinical oncology. The journal also aims to encourage technical evaluations and case studies as well as equipment reviews that will be of interest to an international radiotherapy audience.